08:00 , Jan 19, 2015 |  BC Week In Review  |  Financial News

CoLucid completes venture financing

CoLucid Pharmaceuticals Inc. , Durham, N.C.   Business: Neurology   Date completed: 2015-01-13   Type: Venture financing   Raised: $37.1 million   Investors: TVM Capital; Novo Ventures; Auriga Partners; Pappas Ventures; Domain Associates; Care Capital;...
02:28 , Jan 14, 2015 |  BC Extra  |  Financial News

Migraine play CoLucid raises $37.1M

CoLucid Pharmaceuticals Inc. (Durham, N.C.) raised $37.1 million in a series C round led by TVM Capital Life Science. New investors included Novo Ventures and Auriga Partners. Existing investors Pappas Ventures; Domain Associates; Care Capital;...
08:00 , Jan 12, 2015 |  BC Week In Review  |  Financial News

Vaxart completes venture financing

Vaxart Inc. , San Francisco, Calif.   Business: Infectious   Date completed: 2015-01-08   Type: Venture financing   Raised: $18.4 million   Investor: Care Capital   Note: The financing is a convertible note.  ...
07:00 , Sep 30, 2013 |  BC Week In Review  |  Financial News

Inotek completes venture financing

Inotek Pharmaceuticals Corp. , Lexington, Mass.   Business: Ophthalmic, Renal, Autoimmune   Date completed: 9/27/13   Type: Venture financing   Raised: $21 million   Investors: Devon Park Bioventures; Rho Ventures; Care Capital; MedImmune Ventures; Pitango;...
01:00 , Sep 28, 2013 |  BC Extra  |  Financial News

Inotek raises $28 million

Inotek Pharmaceuticals Corp. (Lexington, Mass.) raised $21 million in a series B round and $7 million in a venture debt financing. All existing investors participated in the venture round, including Devon Park Bioventures; Rho Ventures;...
07:00 , Aug 12, 2013 |  BC Week In Review  |  Financial News

Vaxart completes venture financing

Vaxart Inc. , San Francisco, Calif.   Business: Infectious   Date completed: 7/24/13   Type: Venture financing   Raised: $20 million   Investors: Care Capital; Quantum Technology Partners; Life Science Angels; Sand Hill Angels; Bay...
23:38 , Aug 7, 2013 |  BC Extra  |  Financial News

Vaxart raises $20 million in C round

Oral vaccine company Vaxart Inc. (San Francisco, Calif.) raised $20 million in a series C round led by existing investor Care Capital. Existing investors Quantum Technology Fund; Life Science Angels; Sand Hill Angels; and Bay...
07:00 , Sep 3, 2012 |  BC Week In Review  |  Company News

Elevation Pharmaceuticals, Dainippon Sumitomo deal

Dainippon's Sunovion Pharmaceuticals Inc. subsidiary will acquire Elevation for $100 million up front and up to $300 million in development and commercial milestones related to chronic obstructive pulmonary disease (COPD) product EP-101 . Elevation is...
00:19 , Aug 31, 2012 |  BC Extra  |  Company News

Sunovion to acquire Elevation

The Sunovion Pharmaceuticals Inc. subsidiary of Dainippon Sumitomo Pharma Co. Ltd. (Tokyo:4506; Osaka:4506) will acquire Elevation Pharmaceuticals Inc. (San Diego, Calif.) for $100 million up front and up to $300 million in development and commercial...
07:00 , Jul 23, 2012 |  BC Week In Review  |  Financial News

Agile Therapeutics completes venture financing

Agile Therapeutics Inc. , Princeton, N.J.   Business: Genitourinary   Date completed: 7/19/12   Type: Venture financing   Raised: $40 million   Investors: Aisling Capital; Care Capital; Investor Growth Capital; ProQuest Investments; Kaiser Permanente Ventures;...